Swave Photonics raises €6M for holographic display technology Thursday 03/07/2025 Swave Photonics, a spin-off from imec and VUB, has raised an additional €6 million in Series A funding. This follow-on investment will accelerate the development of Swave's innovative holographic display technology for Spatial + AI Computing. Animab secures €10M for antibiotic-free animal health solution Tuesday 01/07/2025 Animab, a VUB-VIB-UGent spin-off, has secured €10 million in Series B funding to launch its innovative antibiotic-free solution for piglet health, tackling antimicrobial resistance. Annual Report 2024 of the Vice-rectorate Innovation & Industry Relations Wednesday 25/06/2025 Discover the real-world impact of VUB's innovative research in 2024 with our newly released Annual Report 2024. From new spin-offs to impactful industry collaborations, check out the full report for all the details. VUB spin-off Axiles Bionics secures €6M for bionic foot rollout Tuesday 24/06/2025 Axiles Bionics has successfully closed the first €6 million tranche of an €8 million Series A financing round. This significant investment will accelerate the global rollout of Lunaris, its cutting-edge biomimetic prosthetic foot, and advance the development of next-generation bionic devices. FC3 Thursday 19/06/2025 The ERIS team proudly announces that the FC3 consortium has received an EU grant. Prof. Hugo Thienpont, Director of Brussels Photonics at Vrije Universiteit Brussels, will coordinate this project for VUB. VUB, ULB and Sibelga Join Forces on Energy and Innovation Wednesday 11/06/2025 VUB, ULB and Sibelga signed a framework agreement to establish a long-term partnership in research, development, education, and training within the energy sector. CSI Cyprus seeks partners for Horizon Europe 2025 Proposals Friday 06/06/2025 The Center for Social Innovation (CSI Cyprus) is actively developing proposals for the upcoming Horizon Europe funding calls under Pillar II, specifically within Cluster 2 'Culture, Creativity, and Inclusive Society' and Cluster 3 'Civil Security for Society'. Spica Therapeutics and VUB/VIB join forces to advance cancer and immune disease therapies Wednesday 04/06/2025 Pioneering biotech company Spica, with headquarters in Belgium and roots and research in Denmark has announced a strategic collaboration with the Vrije Universiteit Brussel (VUB) and VIB. Axiles Bionics Showcased at Expo 2025 Osaka Monday 12/05/2025 VUB spin-off Axiles Bionics takes centre stage in the Belgian Pavilion, showcasing the Lunaris prosthetic foot, which mimics the natural motion of the human ankle. VUB shines at Knowledge for Growth 2025 Friday 09/05/2025 On 8 May, VUB made its mark at Knowledge for Growth 2025. With pitches, panels, and plenty of networking, it was a day full of ideas and meaningful connections. Acclimate Thursday 17/04/2025 The ERIS team proudly announces that the ACCLIMATE consortium has received an EU grant. Prof. Sebastian Oberthür, Director of VUB's Research Centre for Environment, Economy and Energy, will coordinate this project for VUB. PhotonHub PHACTORY offers €15M boost for photonics innovation Tuesday 15/04/2025 A powerful new European photonics initiative — PhotonHub PHACTORY — has launched under the leadership of Brussels Photonics (B-PHOT) at VUB, coordinated by Professor Hugo Thienpont. Backed by €15 million from the European Commission, the programme aims to accelerate product innovation using photonics across industries. Pages « First ‹ Previous 1 2 3 4 (current) 5 6 7 8 9 … Next › Last »
